The WACC of Halozyme Therapeutics Inc (HALO) is 9.1%.
| Range | Selected | |
| Cost of equity | 9.10% - 11.90% | 10.50% |
| Tax rate | 11.30% - 18.90% | 15.10% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 8.0% - 10.3% | 9.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.13 | 1.26 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.10% | 11.90% |
| Tax rate | 11.30% | 18.90% |
| Debt/Equity ratio | 0.25 | 0.25 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 8.0% | 10.3% |
| Selected WACC | 9.1% | |